PRESS RELEASE published on 02/19/2025 at 08:28, 1 year 5 months ago Inside Information / Other news releases Medincell announces successful c.€43 million Global Offering, strengthening funding for expanding BEPO® technology into new molecules and indications, integrating complementary technologies, improving shareholder structure, and enhancing financial flexibility Pharmaceutical Financial Flexibility Medincell Global Offering BEPO® Technology
BRIEF published on 02/18/2025 at 18:57, 1 year 5 months ago Medincell launches a Global Offer of 10% of its capital Profitability Partnerships Medincell Global Offer BEPO Technology
PRESS RELEASE published on 02/18/2025 at 18:52, 1 year 5 months ago Inside Information / Other news releases Medincell launches a Global Offering to expand its BEPO technology reach into new molecules and indications. Funds raised will strengthen licensing opportunities and improve shareholder structure Shareholder Structure Licensing Opportunities Medincell Global Offering BEPO Technology
BRIEF published on 02/06/2025 at 19:35, 1 year 6 months ago EIB Supports Medincell by Waiving Financial Covenants Loan Agreement Credit Facility Medincell Financial Covenants EIB
PRESS RELEASE published on 02/06/2025 at 19:30, 1 year 6 months ago Inside Information / Other news releases The EIB permanently waives two financial covenants in Medincell's loan agreement, showing confidence. €40M credit facility structure and key details explained Loan Agreement Credit Facility Medincell Financial Covenants EIB
BRIEF published on 01/29/2025 at 15:47, 1 year 6 months ago UZEDY® Achieves $117M in Sales in 2024 Teva Pharmaceuticals 2025 Projections UZEDY® Sales Medincell Partnership Olanzapine Injectable
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 6 months ago Inside Information / Other news releases UZEDY® sales reach $117M in 2024, surpassing Teva's expectations. Medincell poised for $160M in 2025 with Olanzapine Long-Acting Injectable near launch. Key partnership and financial insights Sales Partnership Medincell Teva Pharmaceuticals UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 7 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 7 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
BRIEF published on 11/28/2024 at 18:45, 1 year 8 months ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
Published on 08/12/2026 at 13:45, 6 minutes ago Amarc Announces Geophysical Surveys Identifying Major New Sulphide Mineralized Systems Adjacent To The Aurora Porphyry Copper-Gold Discovery
Published on 08/12/2026 at 13:00, 51 minutes ago Rocky Shore Identifies the Mosquito Target Horizon at the Gold Anchor Project
Published on 08/12/2026 at 12:30, 1 hour 21 minutes ago Relevant Gold Commences 5,000-Metre Drill Program and Updates Exploration Model at the Lewiston Project in Wyoming, USA
Published on 08/12/2026 at 11:30, 2 hours 21 minutes ago American Critical Minerals Announces the Execution of the Drilling Contract with Drake Well Service and Mobilization to the Green River Project
Published on 08/12/2026 at 13:38, 12 minutes ago Nebius reports second quarter 2026 financial results
Published on 08/12/2026 at 12:21, 1 hour 30 minutes ago EQS-Adhoc: Klöckner & Co SE: Delisting will take effect on August 12, 2026 in accordance with the resolution of the Frankfurt Stock Exchange
Published on 08/12/2026 at 11:50, 2 hours 1 minute ago German Offtake Partner to Double Volumes to 40,000 tpa
Published on 08/12/2026 at 11:47, 2 hours 3 minutes ago SME bond market H1 2026: Issuance activity picks up, placement becomes more challenging
Published on 08/10/2026 at 18:00, 1 day 19 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 2 days 1 hour ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 2 days 2 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 4 hours ago Number of shares and voting rights - July 2026 (In French only)
